BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Saturday, February 7, 2026
Home
»
Newsletters
» BioWorld
BioWorld
Sep. 14, 2009
View Archived Issues
Regeneron, Sanofi Pull the Plug on Aflibercept Pancreatic Trial
Read More
Plenty of Data and PDUFA Dates to Keep Biotech Busy This Fall
Read More
Other News To Note
Read More
Clinic Roundup
Read More
Financings Roundup
Read More
Discovery Labs to Meet with FDA to Propose Limited Surfaxin Trial
Discovery Laboratories Inc. has not given up on its Surfaxin drug candidate for respiratory distress syndrome, signaling Friday that it would propose a limited clinical trial to gain FDA approval. (BioWorld Today)
Read More
Only 1 H1N1 Shot Needed, Data from Flu Study Shows
Read More
